Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Catalyst Pharmaceutical Partners, Inc. (CPRX)

« Back to company index

CPRX Chatter Timeline

Stock Ticker for CPRX

Most Active Tweeters for CPRX

No tweets found

Recent Tweets for CPRX

chickpea598 @chickpea598
$ONCS $CPRX Catalyst Pharma is another Orphan Drug Company with huge potential to keep an eye on as they move close… https://t.co/P94MuUGQtQ
August 21st 2018, 5:08pm
registrarjourn @registrarjourn
Catalyst Pharmaceuticals $CPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/czCEbwQgge
August 20th 2018, 2:08pm
EnterpriseLeade @EnterpriseLeade
Catalyst Pharmaceuticals $CPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/CQSy8IIM7m
August 20th 2018, 2:08pm
Allstocknews @Allstocknews
$CPRX Catalyst Pharmaceuticals Appoints Dr. Stanley Iyadurai as Vice President of Clinical Development From our Stock News Alerts App
August 20th 2018, 8:08am
ConsumerFeed @ConsumerFeed
Catalyst Pharmaceuticals Inc $CPRX Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/M2mAdCCAfa
August 19th 2018, 9:08pm
alexrome20 @alexrome20
Binance reopen limited user registration Register link and BONUS ? https://t.co/FvxrxuwdVQ ? 08/19 12:08 $CPRX… https://t.co/8QcaSV1VU8
August 19th 2018, 12:08pm
Ironcookies @Ironcookies
$cprx expanding https://t.co/CK5VtNvP00
August 19th 2018, 10:08am
registrarjourn @registrarjourn
Catalyst Pharmaceuticals $CPRX Downgraded by BidaskClub to “Strong Sell” https://t.co/YaFIFQLQED
August 18th 2018, 3:08pm
EnterpriseLeade @EnterpriseLeade
Catalyst Pharmaceuticals $CPRX Downgraded by BidaskClub to “Strong Sell” https://t.co/i4dOF4U9EV
August 18th 2018, 3:08pm
Stock_News_Now @Stock_News_Now
$CPRX: New SEC Filing for CPRX: Form 8-K (No. 0001193125-18-251807): https://t.co/uNy8YKrvcY
August 17th 2018, 5:08pm
usindexlive @usindexlive
As Catalyst Pharmaceuticals $CPRX Shares Rose, Shareholder Great Point Partners Trimmed Its Holding by $2.68 Billio… https://t.co/EIYWNV5aPz
August 17th 2018, 4:08pm
TheMarketsDaily @TheMarketsDaily
Catalyst Pharmaceuticals Inc $CPRX Receives $5.71 Consensus Price Target from Analysts https://t.co/xPfyOrd4hp
August 17th 2018, 1:08pm
dakotafinancial @dakotafinancial
Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/SMioq6L4ur
August 17th 2018, 9:08am
MareaInformativ @MareaInformativ
Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/LVOvYkv5e9
August 17th 2018, 9:08am
TheMarketsDaily @TheMarketsDaily
Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/sukMgOpxR2
August 17th 2018, 9:08am
MareaInformativ @MareaInformativ
Catalyst Pharmaceuticals Inc to Post Q3 2018 Earnings of -$0.11 Per Share, SunTrust Banks Forecasts $CPRX https://t.co/7RbZRxhpKx
August 17th 2018, 6:08am
TickerReport @TickerReport
Catalyst Pharmaceuticals Inc to Post Q3 2018 Earnings of -$0.11 Per Share, SunTrust Banks Forecasts $CPRX https://t.co/vSlf7IIghz
August 17th 2018, 2:08am
dailypoliticaln @dailypoliticaln
Catalyst Pharmaceuticals Inc to Post Q3 2018 Earnings of -$0.11 Per Share, SunTrust Banks Forecasts $CPRX https://t.co/U5d8tz7SLK
August 17th 2018, 2:08am
ThisLincolnian @ThisLincolnian
Catalyst Pharmaceuticals $CPRX Upgraded at Zacks Investment Research https://t.co/SNIdYubZo5
August 16th 2018, 11:08am
WatchlistN @WatchlistN
Weekly Research Analysts’ Ratings Updates for Catalyst Pharmaceuticals $CPRX https://t.co/T9Ilzllefc
August 16th 2018, 11:08am
AmericanBanking @AmericanBanking
Weekly Research Analysts’ Ratings Updates for Catalyst Pharmaceuticals $CPRX https://t.co/wYnLt0B887 #stocks
August 16th 2018, 11:08am
Ironcookies @Ironcookies
RT @bbnsnews: Zacks Investment Research Upgrades Catalyst Pharmaceuticals $CPRX to Buy https://t.co/HFQbVJMXoO
August 16th 2018, 9:08am
bbnsnews @bbnsnews
Zacks Investment Research Upgrades Catalyst Pharmaceuticals $CPRX to Buy https://t.co/HFQbVJMXoO
August 16th 2018, 7:08am
TranscriptDaily @TranscriptDaily
SunTrust Banks Weighs in on Catalyst Pharmaceuticals Inc’s Q3 2018 Earnings $CPRX https://t.co/G2lkNj7cQy
August 16th 2018, 1:08am
MareaInformativ @MareaInformativ
Catalyst Pharmaceuticals $CPRX Posts Earnings Results, Beats Expectations By $0.02 EPS https://t.co/3R50NWLVbx
August 15th 2018, 3:08pm
MareaInformativ @MareaInformativ
Oppenheimer Comments on Catalyst Pharmaceuticals Inc’s Q3 2018 Earnings $CPRX https://t.co/5XhBQuRB7J
August 15th 2018, 9:08am
usindexlive @usindexlive
Great Point Partners Trimmed Its Stake in Catalyst Pharmaceuticals $CPRX as Market Valuation Rose; Central Securiti… https://t.co/rAJgovJDIR
August 15th 2018, 8:08am
AmericanBanking @AmericanBanking
Catalyst Pharmaceuticals Inc Expected to Post Q3 2018 Earnings of -$0.11 Per Share $CPRX https://t.co/fl0gugN51S #stocks
August 15th 2018, 6:08am
ConsumerFeed @ConsumerFeed
Catalyst Pharmaceuticals $CPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/cPneNINZQn
August 15th 2018, 5:08am
ThisLincolnian @ThisLincolnian
Oppenheimer Comments on Catalyst Pharmaceuticals Inc’s Q3 2018 Earnings $CPRX https://t.co/i0zZX2r84u
August 15th 2018, 4:08am
EnterpriseLeade @EnterpriseLeade
BidaskClub Downgrades Catalyst Pharmaceuticals $CPRX to Sell https://t.co/Ox3ApI6tyV
August 14th 2018, 6:08pm
TranscriptDaily @TranscriptDaily
Catalyst Pharmaceuticals $CPRX Lifted to Buy at Zacks Investment Research https://t.co/ebc2nzmI5u
August 14th 2018, 12:08pm
bbnsnews @bbnsnews
Catalyst Pharmaceuticals Inc $CPRX to Post Q3 2018 Earnings of -$0.08 Per Share, Oppenheimer Forecasts https://t.co/lAh07A1nBN
August 14th 2018, 6:08am
dispatchtribune @dispatchtribune
Catalyst Pharmaceuticals Inc $CPRX Receives Consensus Rating of “Buy” from Analysts https://t.co/hREob0MyGV
August 14th 2018, 4:08am
AmericanBanking @AmericanBanking
Catalyst Pharmaceuticals Inc $CPRX Given Average Rating of “Buy” by Brokerages https://t.co/agxJEMpHzS #stocks
August 14th 2018, 4:08am
Ironcookies @Ironcookies
RT @bbnsnews: Catalyst Pharmaceuticals $CPRX Given a $6.00 Price Target at Oppenheimer https://t.co/wgIffDroQk
August 13th 2018, 11:08pm
MareaInformativ @MareaInformativ
Catalyst Pharmaceuticals $CPRX Stock Rating Lowered by BidaskClub https://t.co/66KrghKXWd
August 13th 2018, 7:08pm
registrarjourn @registrarjourn
Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/czCEbwQgge
August 13th 2018, 2:08pm
EnterpriseLeade @EnterpriseLeade
Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/CQSy8IIM7m
August 13th 2018, 2:08pm
ThisLincolnian @ThisLincolnian
Catalyst Pharmaceuticals $CPRX Stock Rating Reaffirmed by HC Wainwright https://t.co/SpvFdD9VWx
August 13th 2018, 2:08pm
WeekHerald @WeekHerald
Catalyst Pharmaceuticals $CPRX Rating Reiterated by HC Wainwright https://t.co/8JGk1Wa6Fu
August 13th 2018, 2:08pm
bbnsnews @bbnsnews
Catalyst Pharmaceuticals $CPRX Given a $6.00 Price Target at Oppenheimer https://t.co/wgIffDroQk
August 13th 2018, 12:08pm
Ironcookies @Ironcookies
RT @MareaInformativ: Oppenheimer Reiterates $6.00 Price Target for Catalyst Pharmaceuticals $CPRX https://t.co/gmo2RiG4kc
August 13th 2018, 10:08am
AmericanBanking @AmericanBanking
Q3 2018 EPS Estimates for Catalyst Pharmaceuticals Inc $CPRX Lifted by Analyst https://t.co/QfKdkKJmhK #stocks
August 13th 2018, 3:08am
ZolmaxNews @ZolmaxNews
Q3 2018 EPS Estimates for Catalyst Pharmaceuticals Inc $CPRX Lifted by Analyst https://t.co/36zSrwXDXe
August 13th 2018, 3:08am
MareaInformativ @MareaInformativ
Oppenheimer Reiterates $6.00 Price Target for Catalyst Pharmaceuticals $CPRX https://t.co/gmo2RiG4kc
August 12th 2018, 1:08pm
WatchlistN @WatchlistN
Catalyst Pharmaceuticals $CPRX Earns Buy Rating from HC Wainwright https://t.co/1HYjBwephJ
August 12th 2018, 1:08pm
ConsumerFeed @ConsumerFeed
Oppenheimer Reiterates $6.00 Price Target for Catalyst Pharmaceuticals $CPRX https://t.co/7IUqb0LAi1
August 12th 2018, 1:08pm
WatchlistN @WatchlistN
Catalyst Pharmaceuticals $CPRX Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS https://t.co/DVSNvrDQxH
August 12th 2018, 11:08am
ConsumerFeed @ConsumerFeed
Catalyst Pharmaceuticals $CPRX Downgraded by BidaskClub https://t.co/1zSfGt7Gmu
August 12th 2018, 11:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.